These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

1170 related articles for article (PubMed ID: 33980657)

  • 21. A cross-sectional survey study of the impact of COVID-19 pandemic on the training and quality of life of Italian medical residents in the Lombardy region.
    Abati E; Nelva Stellio L; Manini A; Moroni F; Azzalini L; Vilca LM
    Ann Med; 2022 Dec; 54(1):2326-2339. PubMed ID: 36001504
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Increasing Black, Indigenous and People of Color participation in clinical trials through community engagement and recruitment goal establishment.
    Andrasik MP; Broder GB; Wallace SE; Chaturvedi R; Michael NL; Bock S; Beyrer C; Oseso L; Aina J; Lucas J; Wilson DR; Kublin JG; Mensah GA
    PLoS One; 2021; 16(10):e0258858. PubMed ID: 34665829
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Uptake, effectiveness and safety of COVID-19 vaccines in children and young people in Scotland: Protocol for early pandemic evaluation and enhanced surveillance of COVID-19 (EAVE II).
    Adeloye D; Katikireddi SV; Woolford L; Simpson CR; Shah SA; Agrawal U; Richie LD; Swann OV; Stock SJ; Robertson C; Sheikh A; Rudan I
    J Glob Health; 2021; 11():05026. PubMed ID: 35003715
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Challenges and needs for social behavioural research and community engagement activities during the COVID-19 pandemic in rural Mozambique.
    Magaço A; Munguambe K; Nhacolo A; Ambrósio C; Nhacolo F; Cossa S; Macete E; Mandomando I
    Glob Public Health; 2021 Jan; 16(1):153-157. PubMed ID: 33125306
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Black and Latinx Community Perspectives on COVID-19 Mitigation Behaviors, Testing, and Vaccines.
    Jimenez ME; Rivera-Núñez Z; Crabtree BF; Hill D; Pellerano MB; Devance D; Macenat M; Lima D; Martinez Alcaraz E; Ferrante JM; Barrett ES; Blaser MJ; Panettieri RA; Hudson SV
    JAMA Netw Open; 2021 Jul; 4(7):e2117074. PubMed ID: 34264327
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Vaccine effectiveness of the first dose of ChAdOx1 nCoV-19 and BNT162b2 against SARS-CoV-2 infection in residents of long-term care facilities in England (VIVALDI): a prospective cohort study.
    Shrotri M; Krutikov M; Palmer T; Giddings R; Azmi B; Subbarao S; Fuller C; Irwin-Singer A; Davies D; Tut G; Lopez Bernal J; Moss P; Hayward A; Copas A; Shallcross L
    Lancet Infect Dis; 2021 Nov; 21(11):1529-1538. PubMed ID: 34174193
    [TBL] [Abstract][Full Text] [Related]  

  • 27. The 2020 race towards SARS-CoV-2 specific vaccines.
    Karpiński TM; Ożarowski M; Seremak-Mrozikiewicz A; Wolski H; Wlodkowic D
    Theranostics; 2021; 11(4):1690-1702. PubMed ID: 33408775
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Pre-Vaccine Positivity of SARS-CoV-2 Antibodies in Alberta, Canada during the First Two Waves of the COVID-19 Pandemic.
    Charlton CL; Nguyen LT; Bailey A; Fenton J; Plitt SS; Marohn C; Lau C; Hinshaw D; Lutsiak C; Simmonds K; Kanji JN; Zelyas N; Lee N; Mengel M; Tipples G
    Microbiol Spectr; 2021 Sep; 9(1):e0029121. PubMed ID: 34406813
    [TBL] [Abstract][Full Text] [Related]  

  • 29. "No" to placebo-controlled trials of Covid-19 vaccines.
    Ahmad A; Dhrolia MF
    Indian J Med Ethics; 2021; VI(2):1-7. PubMed ID: 33908356
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Fighting COVID-19: A quick review of diagnoses, therapies, and vaccines.
    Shih HI; Wu CJ; Tu YF; Chi CY
    Biomed J; 2020 Aug; 43(4):341-354. PubMed ID: 32532623
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Clinical trials and the COVID-19 pandemic.
    Retsas S
    Hell J Nucl Med; 2020; 23(1):4-5. PubMed ID: 32361715
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Duration of vaccine effectiveness against SARS-CoV-2 infection, hospitalisation, and death in residents and staff of long-term care facilities in England (VIVALDI): a prospective cohort study.
    Shrotri M; Krutikov M; Nacer-Laidi H; Azmi B; Palmer T; Giddings R; Fuller C; Irwin-Singer A; Baynton V; Tut G; Moss P; Hayward A; Copas A; Shallcross L
    Lancet Healthy Longev; 2022 Jul; 3(7):e470-e480. PubMed ID: 35813279
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Impact and effectiveness of mRNA BNT162b2 vaccine against SARS-CoV-2 infections and COVID-19 cases, hospitalisations, and deaths following a nationwide vaccination campaign in Israel: an observational study using national surveillance data.
    Haas EJ; Angulo FJ; McLaughlin JM; Anis E; Singer SR; Khan F; Brooks N; Smaja M; Mircus G; Pan K; Southern J; Swerdlow DL; Jodar L; Levy Y; Alroy-Preis S
    Lancet; 2021 May; 397(10287):1819-1829. PubMed ID: 33964222
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Postvaccination SARS-COV-2 among Health Care Workers in New Jersey: A Genomic Epidemiological Study.
    Mathema B; Chen L; Chow KF; Zhao Y; Zody MC; Mediavilla JR; Cunningham MH; Composto K; Lee A; Oschwald DM; Germer S; Fennessey S; Patel K; Wilson D; Cassell A; Pascual L; Ip A; Corvelo A; Dar S; Kramer Y; Maniatis T; Perlin DS; Kreiswirth BN
    Microbiol Spectr; 2021 Dec; 9(3):e0188221. PubMed ID: 34787439
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Controlled human infection with SARS-CoV-2 to study COVID-19 vaccines and treatments: bioethics in Utopia.
    Holm S
    J Med Ethics; 2020 Sep; 46(9):569-573. PubMed ID: 32616623
    [TBL] [Abstract][Full Text] [Related]  

  • 36. The attitudes of psychiatric patients towards COVID-19 vaccination in China: a cross-sectional study.
    Ren X; Shen F; Gui Y; Wang W; Xing B; Huang W
    BMC Psychiatry; 2021 Sep; 21(1):475. PubMed ID: 34587935
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Safety and Efficacy of Imatinib for Hospitalized Adults with COVID-19: A structured summary of a study protocol for a randomised controlled trial.
    Emadi A; Chua JV; Talwani R; Bentzen SM; Baddley J
    Trials; 2020 Oct; 21(1):897. PubMed ID: 33115543
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Effectiveness of Pfizer-BioNTech and Moderna Vaccines in Preventing SARS-CoV-2 Infection Among Nursing Home Residents Before and During Widespread Circulation of the SARS-CoV-2 B.1.617.2 (Delta) Variant - National Healthcare Safety Network, March 1-August 1, 2021.
    Nanduri S; Pilishvili T; Derado G; Soe MM; Dollard P; Wu H; Li Q; Bagchi S; Dubendris H; Link-Gelles R; Jernigan JA; Budnitz D; Bell J; Benin A; Shang N; Edwards JR; Verani JR; Schrag SJ
    MMWR Morb Mortal Wkly Rep; 2021 Aug; 70(34):1163-1166. PubMed ID: 34437519
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Individual health behaviours to combat the COVID-19 pandemic: lessons from HIV socio-behavioural science.
    Haberer JE; van der Straten A; Safren SA; Johnson MO; Amico KR; Del Rio C; Andrasik M; Wilson IB; Simoni JM
    J Int AIDS Soc; 2021 Aug; 24(8):e25771. PubMed ID: 34339113
    [TBL] [Abstract][Full Text] [Related]  

  • 40. [Technical guidelines for seasonal influenza vaccination in China (2022-2023)].
    National Immunization Advisory Committee (NIAC) Technical Working Group (TWG) on Influenza Vaccination
    Zhonghua Yu Fang Yi Xue Za Zhi; 2022 Oct; 56(10):1356-1386. PubMed ID: 36274602
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 59.